
About this episode
Selling your business is never easy. Aside from the emotional stress that it provides, it can also be detrimental to the business if it's sold to the wrong company. Oftentimes, during the process, it can also serve as a massive distraction to the operations, harming the business in the process.
In this episode of the M&A Science Podcast, we will discuss how to create a positive exit experience in M&A with Swapnil Shinde, CEO at Zeni.
Things you will learn:
• Reasons for the first exit
• Reacting vs Proactive Exits
• Hardest part of selling a business
• Role of sellers in Integration Planning
• Do's and Don'ts of Buying a company
Episode Timestamps
00:00 Intro
06:31 Reasons for the first exit
09:19 Venture Exit
12:19 Build to sell
14:03 Reacting vs Proactive Exits
16:28 Using Bankers during Exits
19:09 Hardest part of selling a business
21:30 Managing Diligence
24:28 Lessons Learned on Diligence
28:03 Keeping and building relationships
29:29 Role of sellers in Integration Planning
32:29 Reasons why Integration fails
34:49 Worst exit experience
36:31 Making integration successful
38:25 Do's and Don'ts of Buying a company
39:41 Identifying Cultural Fit
This episode is sponsored by our products DealRoom and FirmRoom.
Ready to take your M&A to the next level with software made to manage each stage of the deal process? See how DealRoom can facilitate your next deal at https://www.dealroom.net.
FirmRoom provides 80% cost savings over VDRs that bill by page and delivers a far better user experience to boot. Sign up in under 2 minutes by going to https://www.firmroom.com
Get every episode summarized
Each time M&A Science publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from M&A Science

Cultural Fit Over EBITDA: How Salas O'Brien Built a 30-Merger Program Without a...
M&A Science

Cross-Border M&A: How to Do Deals in Italy with Mauro Sambati and Donato Romano
M&A Science

Four Questions That Defined a $1 Billion Deal with Robert Lovegrove
M&A Science

Stop Falling in Love with the Deal: Guardrails for High-Volume Acquisitions with...
M&A Science